BridgeMD
New treatment option for Acute Coronary Syndromes (ACS)
Official title Patient-centered Personalized Cardiac Rehabilitation in Post Acute Coronary Syndrome (BREAK-trial)
ClinicalTrials.gov ID: NCT07038265
What this study is testing
- What it's testing
- The primary objective of this study is to compare an integrated, multidisciplinar patient-centered CRP (Cardiac Rehabilitation Program) (intervention group) especially focused on covering the needs for the female and fragile population to the usual care conventional CRP (control group)
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged ≥ 18 years
- Patients discharged within the last 30 days after an admission for ACS or in the discharge planning process for an admission for ACS.
- The patient is able to fully communicate with the research team and comply with all study procedures.
- The patient voluntarily signs and dates the informed consent form approved by the ethics committee
You likely can't join if
- Age \<18 years
- Participation in another clinical trial
- Moderate or severe cognitive impairment in the absence of a competent caregiver
- Absence of social support
- Institutionalized patient
- Life expectancy \<1 year
See the full eligibility criteria
- Patient aged ≥ 18 years
- Patients discharged within the last 30 days after an admission for ACS or in the discharge planning process for an admission for ACS.
- The patient is able to fully communicate with the research team and comply with all study procedures.
- The patient voluntarily signs and dates the informed consent form approved by the ethics committee
- Age \<18 years
- Participation in another clinical trial
- Moderate or severe cognitive impairment in the absence of a competent caregiver
- Absence of social support
- Institutionalized patient
- Life expectancy \<1 year
- Candidates for end-of-life care
- Severe psychiatric illness
- Planned cardiac surgery including transplant or circulatory support implant
- Death before hospital discharge in patients included in the hospital discharge planning phase
- Carrier of heart transplant.
- Patient unable or refusing to give written informed consent to participate
- Patients who, in the opinion of the investigator, are unsuitable candidates for the study
The study team makes the final eligibility decision.
Where it's taking place
- L'Hospitalet de Llobregat, Barcelona, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L'Hospitalet de Llobregat, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.